Argentina and Mexico to produce AstraZeneca Covid-19 vaccine

▴ Argentina and Mexico to produce AstraZeneca Covid-19 vaccine
Argentina and Mexico will produce the AstraZeneca COVID-19 vaccine for most of Latin America

Argentina and Mexico will produce the AstraZeneca COVID-19 vaccine for most of Latin America, Argentine President Alberto Fernandez said on Wednesday after a meeting with company executives involved in the project.

Argentina's President Alberto Fernandez gestures during the announcement that Argentina and Mexico will produce and distribute an experimental coronavirus vaccine, at the Olivos Presidential residence, in Buenos Aires, Argentina August 12, 2020.

An agreement signed between British pharmaceutical company AstraZeneca and the biotechnology company mAbxience of the INSUD Group includes transfer of technology to initially produce 150 million doses of the vaccine to supply all of Latin America with the exception of Brazil, the Argentine government said.

“Latin American production will be handled in Argentina and Mexico and that will allow timely and efficient access for all countries in the region,” Fernandez said.

Mexican Foreign Minister Marcelo Ebrard said later on Twitter that the deal had been pushed by Fernandez and Mexican President Andres Manuel Lopez Obrador. He said output of the vaccine could extend to 250 million doses.

AstraZeneca, Britain’s second-largest drugmaker, has long operations in Argentina. The company signed a deal with the foundation of Mexican billionaire Carlos Slim for the production of the vaccine, which is expected to be delivered in the first half of 2021, pending Phase III studies and regulatory approvals.

Mexico would provide more details on Thursday, said Ebrard, who thanked the Slim Foundation for financing production.

Arturo Elias, Slim’s spokesman, said a “very significant” sum was being invested in the scheme, without giving a figure.

“There’s a major economic commitment regardless of whether the vaccine works,” he told Reuters, noting that the foundation would start work immediately.

Fernandez said the deal “gives Argentina the peace of mind of being able to have the vaccine when required and at a reasonable price.”

Argentina, which has passed 5,000 coronavirus fatalities, posted a record daily number of COVID-19 infections on Wednesday with 7,663 new cases. Mexico has registered nearly 55,000 deaths and almost half a million cases.

Worldwide coronavirus cases have surpassed 20.4 million, according to the Johns Hopkins University. More than 12.7 million have recovered, and more than 745,000 have died. Back at home, India's coronavirus case tally has spiked by 66,999 cases in the last 24 hours. As per the latest data issued by the Ministry of Health and Family Welfare (MoHFW), India's COVID-19 case tally has surged to 23,96,638 out of which, 16,95,982 people have recovered while 6,53,622 are still suffering from the virus. COVID-19 death toll in India has gone past 47,000 with a single day jump of 942.ack at home, 

Story Courtesy: www.reuters.com 

Tags : #ArgentinaCovidNewsAug13 #AlbertoFernandez #MexicoCovidNewsAug13 #JohnHopkins #AstraZenecaNesAug13 #AstraZeneca #LatestPharmaNewsAug13 #LatestPharmaUpdateAug13 #mAbxience #InsudGroup

About the Author


Team Medicircle

Related Stories

Loading Please wait...

-Advertisements-




Trending Now

The Role of Genetic Profiles in Alzheimer’s Therapy: APOE4 and Treatment ResponsesMay 08, 2024
Assessing Covishield Safety: Indian Research Offers Reassurance Amidst Rare Side Effect DiscussionsMay 08, 2024
Quadria Capital Invests $102 Million in NephroPlus to Boost Dialysis Services Across AsiaMay 08, 2024
When Your Body Makes Beer: Exploring the Curious Case of Auto-Brewery SyndromeMay 07, 2024
Hair Today, Gone Tomorrow: Why Guys Go Bald Before Marriage May 07, 2024
Menopausal Transitions and Mental Health: UCL Study Highlights Increased Depression RiskMay 07, 2024
Vasavi Club of Buddhapurnima organised #GoVote, a vote awareness driveMay 06, 2024
Vasavi Club of Buddhapurnima organised #GoVote, a vote awareness driveMay 06, 2024
Harnessing AI for Early Alzheimer's Disease Diagnosis: IIT Indore's BreakthroughMay 06, 2024
Aurobindo Pharma's Bhiwadi Facility Under FDA Scrutiny: Understanding the ObservationsMay 06, 2024
Exploring the Role of Mediator Protein Complex in Cell Division: Implications for Disease ManagementMay 06, 2024
Akshay Tritiya Parna Mahotsav is to be held in the cityMay 04, 2024
Bharti Singh's Battle with Gallstones: Symptoms, Precautions, and Natural RemediesMay 04, 2024
Empowering Women's Health: New Mammogram GuidelinesMay 04, 2024
Rising Temperatures, Rising Risks: Addressing the Challenges of Heat StressMay 04, 2024
Gynoveda, India's First Ayurveda Fertility Company, Expands Reach with New Clinic in Pune, Set to Open 100 Clinics Across India by 2027May 03, 2024
Aptus Value Housing Finance India Limited, a leading Housing Finance Company has declared its financial results for the year ended March 31, 2024. FY 24 ResultsMay 03, 2024
TIPS FOR PREGNANCY CARE DURING SUMMERMay 03, 2024
The deadly intersection: TB and tobacco smoking co-epidemics in Indonesia Dr TARA SINGH BAM – CNSMay 03, 2024
Mintoak Expands Global Footprint with Strategic Leadership AppointmentsMay 03, 2024